Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ligand Pharm (LGND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,121,337
  • Shares Outstanding, K 21,300
  • Annual Sales, $ 141,100 K
  • Annual Income, $ 12,560 K
  • 36-Month Beta 0.96
  • Price/Sales 28.93
  • Price/Cash Flow 50.84
  • Price/Book 8.49

Price Performance

See More
Period Period Low Period High Performance
1-Month
184.02 +5.71%
on 05/22/18
201.30 -3.37%
on 06/06/18
-0.47 (-0.24%)
since 05/18/18
3-Month
149.22 +30.36%
on 05/04/18
201.30 -3.37%
on 06/06/18
+26.13 (+15.52%)
since 03/19/18
52-Week
115.17 +68.90%
on 06/20/17
201.30 -3.37%
on 06/06/18
+78.76 (+68.04%)
since 06/19/17

Most Recent Stories

More News
3 Biotech Stocks Up in the Past Month on Industry Turnaround

We take a look at three biotech stocks whose share price has increased in the past month due to as the biotech industry bounced back in the past month after declining in the initial four months of the...

LGND : 194.96 (+0.76%)
VVUS : 0.81 (-2.41%)
JNJ : 122.35 (+0.85%)
BMRN : 96.05 (+0.49%)
The Zacks Analyst Blog Highlights: Illumina, Athersys, EyePoint Pharmaceuticals, Rhythm Pharmaceuticals and Ligand Pharmaceuticals

The Zacks Analyst Blog Highlights: Illumina, Athersys, EyePoint Pharmaceuticals, Rhythm Pharmaceuticals and Ligand Pharmaceuticals

LGND : 194.96 (+0.76%)
ILMN : 284.99 (-1.34%)
RYTM : 25.67 (-10.87%)
EYPT : 2.03 (+1.00%)
ATHX : 2.11 (-8.66%)
Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up

Kitov Pharma (KTOV) gained as the FDA approved Consensi (amlodipine and celecoxib) oral tablets for the treatment of osteoarthritis pain and hypertension.

LGND : 194.96 (+0.76%)
KTOV : 2.69 (-2.16%)
HZNP : 17.54 (+0.57%)
PFE : 36.20 (+0.11%)
"Right To Try" Brings Good News for Biotech Sector: 5 Picks

Passage of the Right To Try law and WHO's focus on assessing the quality of bio-similar drugs is expected to benefit biotech stocks.

LGND : 194.96 (+0.76%)
ILMN : 284.99 (-1.34%)
RYTM : 25.67 (-10.87%)
EYPT : 2.03 (+1.00%)
ATHX : 2.11 (-8.66%)
Catalyst's Fridapse Gets Priority Review by FDA, Shares Up

The FDA grants Priority Review to Catalyst's (CPRX) lead pipeline candidate, Firdapse, and set an action date of Nov 28, 2018.

LGND : 194.96 (+0.76%)
ILMN : 284.99 (-1.34%)
BMRN : 96.05 (+0.49%)
CPRX : 3.40 (-2.58%)
5 Biotech Stocks to Boost Your Portfolio's Health This Year

Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio.

AGLE : 10.66 (-2.11%)
CELG : 79.33 (+2.06%)
LGND : 194.96 (+0.76%)
CRSP : 61.38 (-2.00%)
BMRN : 96.05 (+0.49%)
ATHX : 2.11 (-8.66%)
SNY : 39.22 (-0.93%)
Allergan Recalls Taytulla Oral Contraceptives, Stock Down

Allergan (AGN) recalls some sample packs of Taytulla oral birth control pills. Shares decline.

LGND : 194.96 (+0.76%)
LLY : 86.47 (+0.42%)
AGN : 172.32 (+0.35%)
BMRN : 96.05 (+0.49%)
Bayer's Generic Competition, Pipeline Setback Issues Remain

Generic threats/competition for many of its products remain a concern for Bayer (BAYRY).

BAYRY : 31.8000 (+1.44%)
LGND : 194.96 (+0.76%)
ILMN : 284.99 (-1.34%)
ENTA : 113.30 (-0.63%)
Prothena Restructures Resources, to Cut Workforce by 57%

Prothena announces a reduction in workforce by 57%, due to the discontinuation of lead program, NEOD001.

CELG : 79.33 (+2.06%)
LGND : 194.96 (+0.76%)
PRTA : 14.45 (-0.76%)
RHHBY : 26.4100 (+0.08%)
AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint

AbbVie's (ABBV) phase III iLLUMINA study evaluating Imbruvica in combination with Gazyva meets its primary endpoint of improvement in progression-free survival.

LGND : 194.96 (+0.76%)
ILMN : 284.99 (-1.34%)
JNJ : 122.35 (+0.85%)
ABBV : 97.66 (-0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade LGND with:

Business Summary

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases....

See More

Key Turning Points

2nd Resistance Point 198.22
1st Resistance Point 195.85
Last Price 194.96
1st Support Level 190.28
2nd Support Level 187.07

See More

52-Week High 201.30
Last Price 194.96
Fibonacci 61.8% 168.40
Fibonacci 50% 158.24
Fibonacci 38.2% 148.07
52-Week Low 115.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar